Asabys Partners

MedLumics, S.L., compañía del portfolio de Asabys, cierra una nueva ronda de financiación, soportada por #CDTIInnvierte. Gracias CDTI Innovación - Centro para el Desarrollo Tecnológico y la Innovación por vuestro apoyo! Seguimos!

Thrilled to share article from La Vanguardia detailing a recent trip to Shenzhen by a small group of forward-thinking Catalan businessmen and businesswomen. This journey, aimed at fostering innovation and exploring new business opportunities, has been a significant step towards strengthening ties between Catalonia and China. What makes this article particularly special for us is the participation of our Managing Partner, Josep Ll. Sanfeliu. His presence in this delegation underscores our commitment to global collaboration and staying at the forefront of technological and business advancements. The article reflects the impressive development of China in the areas of health technology, innovation both in medtech and in biotech. The visit to the country and to Shenzhen perfectly exemplifies where the future of healthcare is going and Asabys Partners is trying to capture those technologies in its investment activity since it's just a window to the future of healthcare. China still represents an opportunity but also faces many challenges ahead in managing its own healthcare needs and social coverage for its population. In summary, healthcare innovation, technology and the need to invest in that space is key for the future of society.

Asabys Partners attended the Catalonia.Health (CataloniaBio & HealthTech) BBQ once again! This summer tradition is always a highlight! Thank you for hosting such a fantastic event! #biotech #lifesciences

Avui el nostre Soci Director, Josep Ll. Sanfeliu ha assistit a la Presentació del Pla Estratègic de Ciència i Innovació 2024-2027 al Saló de Cent de l’Ajuntament de Barcelona. Gràcies Barcelona Activa pel compromís en el futur de la ciència i la innovació de la nostra ciutat.

Felicidades a Centre for Genomic Regulation (CRG) y a Instituto de Recursos Naturales y Agrobiología Sevilla por estos merecidos reconocimientos y un especial agradecimiento a la Fundación Banco Sabadell por su continuo apoyo y compromiso con el progreso de la investigación y del desarrollo del talento joven.

“Enhorabuena y agradecimientos a Enisa con el emprendimiento innovador por las primeras 1.000 empresas emergentes certificadas. Agente clave del ecosistema start-up español y su crecimiento, por muchos años de seguir trabajando juntos, estimulando la innovación en España. Gracias también a Barcelona City Council y Fundación Cotec para la Innovación”

We are pleased to announce our investment in Augustine Therapeutics, marking the 5th investment of our fund Sabadell Asabys II (Banco Sabadell ), co-investing with Eli Lilly and Company.   Augustine Therapeutics is a pioneering biotech company in the development of new molecules for the treatment of neurodegenerative and cardiometabolic diseases. The round also involved the participation of CMT Research Foundation too, as well as the existing investors AdBio partners, V-Bio Ventures, PMV Pharmaceuticals, Inc., VIB, and GEMMA FRISIUS - FONDS K.U.LEUVEN (the venture capital division of KU Leuven). With the support of our partners Banco Sabadell European Investment Fund (EIF), Alantra https://lnkd.in/djRWVcMC

We are proud to share that two of our company creations – Nuage Therapeutics (2023) and ONA Therapeutics (2021)– have been honoured with the “National Innovation Award for the creation of Scientific Based Companies" This recognition underscores the critical role of strong seed investment in driving these companies forward and establishing them as industry leaders. Congratulations to Xavier Salvatella, Valerie Vanhooren Orgullosos de compartir que dues de les empreses que hem ajudat a néixer -Nuage Therapeutics (2023) i ONA Therapeutics (2021)- han estat guardonades amb el "Premi Nacional d'Innovació per la Creació d'Empreses de Base Científica". Aquest reconeixement subratlla el paper crític d'una forta inversió seed per impulsar aquestes companyies i establir-les com a líders del sector. Enhorabona a Xavier Salvatella, Valerie Vanhooren #PRN23 #PRN21 #FCRI

Congratulations to our portfolio company Sidekick Health for the acquisition of PINK!. Together, they are set to drive forward innovation and provide unparalleled support in the healthcare sector including further opportunities within women’s health and oncology. Exciting times ahead for digital health! #DigitalHealth #Innovation #Healthcare https://lnkd.in/d6mN8CjC

Excited to be part of the #HLTH Conference in Amsterdam. Looking forward to sharing time with innovators, investors and broader healthcare professionals. Our Partner Guillem Masferrer is there, don’t hesitate to drop him a line!